The litigation that began in state court over the diabetes drug Invokana should be handled in federal court, a district judge has ruled.

U.S. District Judge Mitchell S. Goldberg of the Eastern District of Pennsylvania ruled Wednesday in Portnoff v. Janssen Pharmaceuticals that the federal courts should keep jurisdiction over the 106 Invokana cases that were filed last year in the Philadelphia Court of Common Pleas.